Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural killer (NK) cell antigens refer to the surface molecules and receptors expressed on NK cells, a type of cytotoxic lymphocyte critical to the innate immune system. NK cells play a key role in immune surveillance by targeting virus-infected, stressed, or malignant cells without requiring prior sensitization or antigen-specific recognition. These antigens include both activating and inhibitory receptors that regulate whether an NK cell will kill a target cell. Key examples include KIRs, NKG2D, CD16, and NCRs. Alterations in expression or function of natural killer cell antigens can impact susceptibility to infections, cancer progression, autoimmune diseases, transplant outcomes, and efficacy of immunotherapies targeting these pathways.
Modulation of NK cell activity via targeting surface receptors (agonism or antagonism). Antibody-dependent cellular cytotoxicity (ADCC). Enhancement of NK cell mediated killing by blocking inhibitory signals or promoting activating signals.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural Killer Cell Antigens (NK Cell Antigens).